Ricciardi, G.; Giuliani, G.; Armando, A.; Quitadamo, R.; Demita, R.; Stigliani, C.
DAC®, a Hyaluronan Derivative in the Form of a Gel, Is Effective in Preventing Periprosthetic Joint Infection During Arthroplasty Revision in Patients with Comorbidities: A Retrospective, Observational, 1:1-Matched Case–Control Clinical Investigation. Biomedicines 2025, 13, 2408.
https://doi.org/10.3390/biomedicines13102408
AMA Style
Ricciardi G, Giuliani G, Armando A, Quitadamo R, Demita R, Stigliani C.
DAC®, a Hyaluronan Derivative in the Form of a Gel, Is Effective in Preventing Periprosthetic Joint Infection During Arthroplasty Revision in Patients with Comorbidities: A Retrospective, Observational, 1:1-Matched Case–Control Clinical Investigation. Biomedicines. 2025; 13(10):2408.
https://doi.org/10.3390/biomedicines13102408
Chicago/Turabian Style
Ricciardi, Giuseppe, Giancarlo Giuliani, Arminio Armando, Raffaele Quitadamo, Rosario Demita, and Costantino Stigliani.
2025. "DAC®, a Hyaluronan Derivative in the Form of a Gel, Is Effective in Preventing Periprosthetic Joint Infection During Arthroplasty Revision in Patients with Comorbidities: A Retrospective, Observational, 1:1-Matched Case–Control Clinical Investigation" Biomedicines 13, no. 10: 2408.
https://doi.org/10.3390/biomedicines13102408
APA Style
Ricciardi, G., Giuliani, G., Armando, A., Quitadamo, R., Demita, R., & Stigliani, C.
(2025). DAC®, a Hyaluronan Derivative in the Form of a Gel, Is Effective in Preventing Periprosthetic Joint Infection During Arthroplasty Revision in Patients with Comorbidities: A Retrospective, Observational, 1:1-Matched Case–Control Clinical Investigation. Biomedicines, 13(10), 2408.
https://doi.org/10.3390/biomedicines13102408
